🧬 Genetic Disorder

Ehlers-Danlos Syndrome

Also known as: EDS, Ehlers-Danlos Syndromes

Ehlers-Danlos syndromes are a group of inherited connective tissue disorders caused by abnormalities in the structure, production, or processing of collagen. They are characterized by joint hypermobility, skin hyperextensibility, and tissue fragility.

👥 1 in 5,000 (all types combined) Prevalence
🔬 42 Active Trials

Ehlers-Danlos syndrome happens when the 'glue' (collagen) that holds our body together doesn't work properly. This makes joints extra bendy and skin extra stretchy. While there's no cure, doctors can help manage symptoms and prevent injuries.

Signs & Symptoms

  • Hypermobile joints
  • Stretchy, fragile skin
  • Easy bruising
  • Chronic pain
  • Fatigue
  • Digestive problems
  • Dizziness and fainting
  • Poor wound healing
  • Joint dislocations
  • Heart valve problems

Treatment Options

THERAPY FDA Approved

Physical therapy

HIGHLY EFFECTIVE
MEDICATION FDA Approved

Pain management

MODERATELY EFFECTIVE
SURGERY FDA Approved

Joint stabilization surgery

MODERATELY EFFECTIVE
SUPPORTIVE FDA Approved

Cardiovascular monitoring (vascular EDS)

HIGHLY EFFECTIVE

Diagnosis

  • Clinical examination using diagnostic criteria
  • Beighton score for hypermobility
  • Genetic testing
  • Skin biopsy
  • Echocardiogram
  • Family history assessment

History

EDS is named after Edvard Ehlers and Henri-Alexandre Danlos who independently described the condition in the early 1900s. The classification has evolved significantly, with the current 2017 nosology recognizing 13 subtypes based on clinical features and genetic findings.

Recent Breakthroughs

2024

Gene therapy research advances

Early-stage research into gene therapy approaches for vascular EDS shows promising safety profiles.

2023

hEDS genetic research

Large-scale genomic studies identify potential genetic contributors to hypermobile EDS.